A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease

Clinical trial NCT02017340 · COMPLETED

Trial details

NCT number: NCT02017340
Sponsor: Prof Brian Lawlor
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2013-04-24
Primary completion: 2016-12-16
Enrollment: 511

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.